Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B

Alzheimer's and Dementia

Volumn 8, Issue 6, 2012, Pages 496-501

  Handen, Benjamin L ^a   Cohen, Ann D ^a   Channamalappa, Umapathy ^a   Bulova, Peter ^a   Cannon, Sheila A ^a   Cohen, William I ^a   Mathis, Chester A ^a   Price, Julie C ^a   Klunk, William E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid deposition; Down syndrome; Intellectual disability; Pittsburgh compound B

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN SYNDROME; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AMYLOIDOGENIC PROTEINS; ANILINE COMPOUNDS; BRAIN; DOWN SYNDROME; FEMALE; HUMANS; MALE; NEUROIMAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THIAZOLES; YOUNG ADULT;

EID: 84867893925     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.09.229     Document Type: Article

References (38)

1. E.B. Hook, P.K. Cross, and D.M. Schreinemachers Chromosomal abnormality rates at amniocentesis and in live-born infants JAMA 249 1983 2034 2038
2. W.B. Zigman, N. Schupf, D.A. Devenny, C. Miezejeski, R. Ryan, and T.K. Urv Incidence and prevalence of dementia in elderly adults with mental retardation without Down syndrome Am J Ment Retard 109 2004 126 141
3. M.P. Janicki, and A.J. Dalton Prevalence of dementia and impact on intellectual disability services Ment Retard 38 2000 276 288
4. M.P. Janicki, A.J. Dalton, C.M. Henderson, and P.W. Davidson Mortality and morbidity among older adults with intellectual disability: health services considerations Disabil Rehab 21 1999 284 294
5. F.E. Visser, A.P. Aldenkamp, A.C. van Huffelen, M. Kuilman, J. Overweg, and J. van Wijk Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome Am J Ment Retard 101 1997 400 412
6. Q. Malone Mortality and survival of the Down's syndrome population in Western Australia J Ment Defic Res 32 Pt. 1 1988 59 65
7. D. Strauss, and R.K. Eyman Mortality of people with mental retardation in California with and without Down syndrome, 1986-1991 Am J Ment Retard 100 1996 643 653
8. V.P. Prasher, and A. Filer Behavioural disturbance in people with Down's syndrome and dementia J Intellect Disabil Res 39 Pt. 5 1995 432 436
9. J. Landt, J.C. D'Abrera, A.J. Holland, F.I. Aigbirhio, T.D. Fryer, and R. Canales Using positron emission tomography and carbon 11-labeled Pittsburgh compound B to image brain fibrillar {beta}-amyloid in adults with Down syndrome: safety, acceptability, and feasibility Arch Neurol 68 2011 890 896
10. D.A. Devenny, S.J. Krinsky-McHale, G. Sersen, and W.P. Silverman Sequence of cognitive decline in dementia in adults with Down's syndrome J Intellect Disabil Res 44 Pt. 6 2000 654 665
11. B.T. Hyman Down syndrome and Alzheimer disease Progress Clin Bio Res 379 1992 123 142
12. N. Schupf, D. Kapell, B. Nightingale, A. Rodriguez, B. Tycko, and R. Mayeux Earlier onset of Alzheimer's disease in men with Down syndrome Neurol 50 1998 991 995
13. L. Hebert, P. Scherr, J. Bienias, D. Bennett, and D. Evans Alzheimer's disease in the U.S. population: prevalence estimates using the 2000 census Arch Neurol 60 2003 1119 1122
14. B.T. Hyman, H.L. West, G.W. Rebeck, F. Lai, and D.M. Mann Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype Arch Neurol 52 1995 373 378
15. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, and L.M. Brownlee The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
16. Workgroup The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease Neurobiol Aging 18 Suppl 1997 S1 S2
17. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, and S.K. Ziolko Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J Neurosci 27 2007 6174 6184
18. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann Neurol 55 2004 306 319
19. G.H. Roid Stanford-Binet Intelligence Test Scales 2003 Riverside Publishing Itasca, IL
20. M. Panisset, M. Roudier, J. Saxton, and F. Boller Severe impairment battery. A neuropsychological test for severely demented patients Arch Neurol 51 1994 41 45
21. B.J. Lopresti, W.E. Klunk, C.A. Mathis, J.A. Hoge, S.K. Ziolko, and X. Lu Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis J Nucl Med 46 2005 1959 1972
22. J.C. Price, W.E. Klunk, B.J. Lopresti, X. Lu, J.A. Hoge, and S.K. Ziolko Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B J Cereb Blood Flow Metab 25 2005 1528 1547
23. C. Meltzer, P. Kinahan, P. Greer, T.E. Nichols, C. Comtat, M.N. Cantwell, M.P. Lin, and J.C. Price Comparative evaluation of MR-based partial volume correction schemes for PET J Nucl Med 40 1999 2053 2065
24. A.D. Cohen, J.C. Price, L.A. Weissfeld, J. James, B.L. Rosario, and W. Bi Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: an example of brain reserve J Neurosci 29 2009 14770 14778
25. A.A. Wilson, A. Garcia, A. Chestakova, H.F. Kung, and S. Houle A rapid one-step radiosynthesis of the beta-amyloid imaging radiotracer N-methyl-[C-11]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([C-11]-6-OH-BTA-1) J Label Compd Radiopharm 47 2004 679 682
26. R.L. McNamee, S.H. Yee, J.C. Price, W.E. Klunk, B. Rosario, and L. Weissfeld Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements J Nucl Med 50 2009 348 355
27. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, and N.D. Tsopelas Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
28. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452
29. C.C. Rowe, S. Ng, U. Ackermann, S.J. Gong, K. Pike, and G. Savage Imaging beta-amyloid burden in aging and dementia Neurology 68 2007 1718 1725
30. N.J. Cairns, M.D. Ikonomovic, T. Benzinger, M. Storandt, A.M. Fagan, and A.R. Shah Absence of Pittsburgh compound B detection of cerebral amyloid {beta} in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report Arch Neurol 66 2009 1557 1562
31. I.T. Lott, and E. Head Alzheimer disease and Down syndrome: factors in pathogenesis Neurobiol Aging 26 2005 383 389
32. T. Iwatsubo, D.M. Mann, A. Odaka, N. Suzuki, and Y. Ihara Amyloid beta protein (A beta) deposition: a beta 42(43) precedes A beta 40 in Down syndrome [see comments] Ann Neurol 37 1995 294 299
33. M.D. Ikonomovic, W.E. Klunk, E.E. Abrahamson, C.A. Mathis, J.C. Price, and N.D. Tsopelas Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain 131 Pt. 6 2008 1630 1645
34. S. Jayadev, J.B. Leverenz, E. Steinbart, J. Stahl, W. Klunk, C.E. Yu, and T.D. Bird Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2 Brain 133 Pt. 4 2010 1143 1154
35. J. Koivunen, A. Verkkoniemi, S. Aalto, A. Paetau, J.P. Ahonen, and M. Viitanen PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease Brain 131 Pt. 7 2008 1845 1853
36. A.M. Remes, L. Laru, H. Tuominen, S. Aalto, N. Kemppainen, and H. Mononen Carbon 11-labeled Pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication Arch Neurol 65 2008 540 544
37. V.L. Villemagne, S. Ataka, T. Mizuno, W.S. Brooks, Y. Wada, and M. Kondo High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types Arch Neurol 66 2009 1537 1544
38. A.K. Läck, K.E. Gill, and L.J. Porrino Local cerebral glucose utilization in rats exposed to an enriched environment: a comparison to impoverishment Pharmacol Biochem Behav 96 2010 521 525